JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruggiero, S.L.
Right arrow Articles by Drew, S.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruggiero, S.L.
Right arrow Articles by Drew, S.J.
J Dent Res 86(11):1013-1021, 2007
© 2007 International and American Associations for Dental Research


REVIEW
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE

Osteonecrosis of the Jaws and Bisphosphonate Therapy

S.L. Ruggiero1,2,*, and S.J. Drew2

1 Department of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Long Island Jewish Medical Center, Division of Oral and Maxillofacial Surgery, New Hyde Park, NY; and
2 New York Center for Orthognathic and Maxillofacial Surgery, 2001 Marcus Ave., Suite N10, Lake Success, NY 11042, USA

* corresponding author, sruggie{at}optonline.net

Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. The efficacy of these agents in treating and preventing the significant skeletal complications associated with these conditions has had a major positive impact for patients and is responsible for their widespread use in medicine. Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant complication in a subset of patients receiving these drugs. Based on a growing number of case reports and institutional reviews, bisphosphonate therapy may cause exposed and necrotic bone that is isolated to the jaw. This complication usually presents following simple dento-alveolar surgery, and can cause a significant adverse effect on the quality of life for most patients. The pathogenesis for this complication appears to be related to the profound inhibition of osteoclast function and bone remodeling.

KEY WORDS: bone • bisphosphonate • BRONJ • mandible • osteonecrosis • osteoporosis • jaw




This article has been cited by other articles:


Home page
Journal of the American Dental AssociationHome page
M. Etminan and K. Aminzadeh
BISPHOSPHONATES AND ONJ
J Am Dent Assoc, May 1, 2008; 139(5): 535 - 536.
[Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
M. Glick
Closing in on the Puzzle of ONJ
J Am Dent Assoc, January 1, 2008; 139(1): 12 - 15.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2007 Institutional Access Guidelines